KRYSTAL BIOTECH INCKRYSTAL BIOTECH INCKRYSTAL BIOTECH INC

KRYSTAL BIOTECH INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.72 B‬EUR
3.00EUR
‪86.13 M‬EUR
‪280.63 M‬EUR
‪24.51 M‬
Beta (1Y)
1.29
Employees (FY)
275
Change (1Y)
+46 +20.09%
Revenue / Employee (1Y)
‪1.02 M‬EUR
Net income / Employee (1Y)
‪313.18 K‬EUR

About Krystal Biotech, Inc.


CEO
Krish S. Krishnan
Headquarters
Pittsburgh
Founded
2016
FIGI
BBG00MDVCTY4
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.


Frequently Asked Questions


The current price of 4KB is 164.55 EUR — it has decreased by −1.46% in the past 24 hours. Watch KRYSTAL BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange KRYSTAL BIOTECH INC stocks are traded under the ticker 4KB.
4KB stock has fallen by −2.11% compared to the previous week, the month change is a 9.05% rise, over the last year KRYSTAL BIOTECH INC has showed a 0.34% increase.
We've gathered analysts' opinions on KRYSTAL BIOTECH INC future price: according to them, 4KB price has a max estimate of 230.58 EUR and a min estimate of 183.53 EUR. Watch 4KB chart and read a more detailed KRYSTAL BIOTECH INC stock forecast: see what analysts think of KRYSTAL BIOTECH INC and suggest that you do with its stocks.
4KB reached its all-time high on Jul 26, 2024 with the price of 203.10 EUR, and its all-time low was 35.80 EUR and was reached on Nov 26, 2021. View more price dynamics on 4KB chart.
See other stocks reaching their highest and lowest prices.
4KB stock is 1.54% volatile and has beta coefficient of 1.29. Track KRYSTAL BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is KRYSTAL BIOTECH INC there?
Today KRYSTAL BIOTECH INC has the market capitalization of ‪4.72 B‬, it has increased by 1.51% over the last week.
Yes, you can track KRYSTAL BIOTECH INC financials in yearly and quarterly reports right on TradingView.
KRYSTAL BIOTECH INC is going to release the next earnings report on May 12, 2025. Keep track of upcoming events with our Earnings Calendar.
4KB earnings for the last quarter are 1.47 EUR per share, whereas the estimation was 1.14 EUR resulting in a 28.36% surprise. The estimated earnings for the next quarter are 1.36 EUR per share. See more details about KRYSTAL BIOTECH INC earnings.
KRYSTAL BIOTECH INC revenue for the last quarter amounts to ‪88.04 M‬ EUR, despite the estimated figure of ‪87.56 M‬ EUR. In the next quarter, revenue is expected to reach ‪91.06 M‬ EUR.
4KB net income for the last quarter is ‪43.93 M‬ EUR, while the quarter before that showed ‪24.41 M‬ EUR of net income which accounts for 79.96% change. Track more KRYSTAL BIOTECH INC financial stats to get the full picture.
No, 4KB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 13, 2025, the company has 275.00 employees. See our rating of the largest employees — is KRYSTAL BIOTECH INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KRYSTAL BIOTECH INC EBITDA is ‪106.13 M‬ EUR, and current EBITDA margin is 37.84%. See more stats in KRYSTAL BIOTECH INC financial statements.
Like other stocks, 4KB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KRYSTAL BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KRYSTAL BIOTECH INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KRYSTAL BIOTECH INC stock shows the buy signal. See more of KRYSTAL BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.